Literature DB >> 24225578

Newly available antibodies with practical applications in surgical pathology.

John K C Chan1.   

Abstract

Selected antibodies that have become available in recent years and have applications in diagnostic pathology are discussed. They include antibodies that are organ-related, provide information on cellular differentiation or histogenetic type, have predictive value in tumors, and highlight infective agents. PAX8 (paired box gene 8) is a marker expressed in the lower female genital tract, thyroid, and kidney and their tumors. Napsin A is expressed in the lung and kidney and is an alternative marker for pulmonary adenocarcinoma. Arginase A is a sensitive and specific marker for liver tumors. ERG (Ets-related gene) is an excellent marker for endothelium and vascular tumors as well as prostatic cancer (about 50% of cases). SOX10 (SRY-related HMG box) is expressed predominantly in melanocytic and Schwann cells and the corresponding tumors. DOG1 (discovered on GIST 1) is an excellent marker for gastrointestinal stromal tumor (GIST) and acinic cell carcinoma. OCT3/4 is a pan-germ cell tumor marker, except yolk sac tumor. SALL4 is positive in various types of germ cell tumors, including yolk sac tumor. MUC4 (mucin-related antigen 4) is a sensitive and specific marker for low-grade fibromyxoid sarcoma. Langerin is a specific marker for Langerhans cells and their tumors. SOX11 is a sensitive marker for mantle cell lymphoma. New generation antibodies against anaplastic lymphoma kinase (ALK) are required to reliably demonstrate ALK gene translocation in pulmonary carcinomas. Lack of expression of succinate dehydrogenase B is seen in paragangliomas of the hereditary form and in the pediatric type of GIST. Antibodies against Trepenoma pallidum can facilitate the diagnosis of syphilis, whereas those against SV40 (simian virus 40) are helpful for diagnosis of BK virus infection and progressive multifocal leukoencephalopathy.

Entities:  

Keywords:  ALK; Arginase 1; DOG1; ERG; Langerin; MUC4; Napsin A; OCT3/4; PAX8; SALL4; SOX10; SOX11; SV40; Treponema pallidum; antibodies; immunohistochemistry; succinate dehydrogenase

Mesh:

Substances:

Year:  2013        PMID: 24225578     DOI: 10.1177/1066896913507601

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  6 in total

1.  Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland.

Authors:  Min-Shu Hsieh; Yueh-Hung Chou; Shin-Joe Yeh; Yih-Leong Chang
Journal:  Virchows Arch       Date:  2015-05-15       Impact factor: 4.064

2.  Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.

Authors:  Fernanda Viviane Mariano; Camila Andrea Concha Gómez; Juliana de Souza do Nascimento; Harim Tavares Dos Santos; Erika Said Egal; Victor Angelo Martins Montalli; Pablo Agustin Vargas; Oslei Paes de Almeida; Albina Altemani
Journal:  Head Neck Pathol       Date:  2016-05-13

3.  Sox10 expression in ovarian epithelial tumors is associated with poor overall survival.

Authors:  Ah-Young Kwon; Ilyeong Heo; Hye Jin Lee; Gwangil Kim; Haeyoun Kang; Jin-Hyung Heo; Tae Hoen Kim; Hee Jung An
Journal:  Virchows Arch       Date:  2016-03-07       Impact factor: 4.064

4.  Epithelioid angiosarcoma of the thyroid gland without distant metastases at diagnosis: report of six cases with a long follow-up.

Authors:  Paola Collini; Marta Barisella; Salvatore L Renne; Natalia Pizzi; Davide Mattavelli; Silvia Stacchiotti; Franco Mattavelli
Journal:  Virchows Arch       Date:  2016-05-26       Impact factor: 4.064

5.  Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by 18F-FDG PET/CT: a Case Report and Review of Literature.

Authors:  Dominique Fuser; Matthew L Hedberg; Louis P Dehner; Farrokh Dehdashti; Barry A Siegel
Journal:  J Kidney Cancer VHL       Date:  2018-01-12

Review 6.  Sex-Determining Region Y Chromosome-Related High-Mobility-Group Box 10 in Cancer: A Potential Therapeutic Target.

Authors:  Liming Yu; Fan Peng; Xue Dong; Ying Chen; Dongdong Sun; Shuai Jiang; Chao Deng
Journal:  Front Cell Dev Biol       Date:  2020-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.